Literature DB >> 18848883

B-cell tolerance checkpoints in health and autoimmunity.

Eric Meffre1, Hedda Wardemann.   

Abstract

The enormous diversity of the antibody repertoire is generated by two mechanisms: recombination of immunoglobulin (Ig) gene variable (V), diversity (D), and joining (J) gene segments during the early stages of B-cell development in the bone marrow and somatic hypermutation (SHM) of functional Ig genes from antigen-activated B cells within secondary lymphoid organs. Diversity by V(D)J recombination and SHM not only provides protective humoral immunity but also generates potentially harmful clones expressing autoantibodies. Under normal circumstances, several mechanisms regulate the removal of autoreactive B cells and defects in central and peripheral B cell tolerance checkpoints are associated with the development of autoimmunity in humans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18848883     DOI: 10.1016/j.coi.2008.09.001

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  139 in total

1.  DBC1 is a suppressor of B cell activation by negatively regulating alternative NF-κB transcriptional activity.

Authors:  Sinyi Kong; Muthusamy Thiruppathi; Quan Qiu; Zhenghong Lin; Hongxin Dong; Eduardo N Chini; Bellur S Prabhakar; Deyu Fang
Journal:  J Immunol       Date:  2014-10-31       Impact factor: 5.422

Review 2.  Prospects for an HIV vaccine: leading B cells down the right path.

Authors:  Susan Moir; Angela Malaspina; Anthony S Fauci
Journal:  Nat Struct Mol Biol       Date:  2011-12-05       Impact factor: 15.369

Review 3.  Polyreactive antibodies in adaptive immune responses to viruses.

Authors:  Hugo Mouquet; Michel C Nussenzweig
Journal:  Cell Mol Life Sci       Date:  2011-11-02       Impact factor: 9.261

4.  High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations.

Authors:  Yu-Chang Wu; David Kipling; Hui Sun Leong; Victoria Martin; Alexander A Ademokun; Deborah K Dunn-Walters
Journal:  Blood       Date:  2010-05-10       Impact factor: 22.113

Review 5.  B Cells, Antibodies, and More.

Authors:  William Hoffman; Fadi G Lakkis; Geetha Chalasani
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-23       Impact factor: 8.237

Review 6.  Approaches to Mitigate the Unwanted Immunogenicity of Therapeutic Proteins during Drug Development.

Authors:  Laura I Salazar-Fontana; Dharmesh D Desai; Tarik A Khan; Renuka C Pillutla; Sandra Prior; Radha Ramakrishnan; Jennifer Schneider; Alexandra Joseph
Journal:  AAPS J       Date:  2017-01-12       Impact factor: 4.009

7.  Dysregulation of B Cell Repertoire Formation in Myasthenia Gravis Patients Revealed through Deep Sequencing.

Authors:  Jason A Vander Heiden; Panos Stathopoulos; Julian Q Zhou; Luan Chen; Tamara J Gilbert; Christopher R Bolen; Richard J Barohn; Mazen M Dimachkie; Emma Ciafaloni; Teresa J Broering; Francois Vigneault; Richard J Nowak; Steven H Kleinstein; Kevin C O'Connor
Journal:  J Immunol       Date:  2017-01-13       Impact factor: 5.422

Review 8.  Activation-induced cytidine deaminase and aberrant germinal center selection in the development of humoral autoimmunities.

Authors:  Ahmad Zaheen; Alberto Martin
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

9.  Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production.

Authors:  Elizabeth Cotzomi; Panos Stathopoulos; Casey S Lee; Alanna M Ritchie; John N Soltys; Fabien R Delmotte; Tyler Oe; Joel Sng; Ruoyi Jiang; Anthony K Ma; Jason A Vander Heiden; Steven H Kleinstein; Michael Levy; Jeffrey L Bennett; Eric Meffre; Kevin C O'Connor
Journal:  Brain       Date:  2019-06-01       Impact factor: 13.501

10.  A cryptic polyreactive antibody recognizes distinct clades of HIV-1 glycoprotein 120 by an identical binding mechanism.

Authors:  Jordan D Dimitrov; Cyril Planchais; Tobias Scheel; Delphine Ohayon; Stephane Mesnage; Claudia Berek; Srinivas V Kaveri; Sébastien Lacroix-Desmazes
Journal:  J Biol Chem       Date:  2014-05-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.